Chemotherapy during pregnancy: Effect of anthracyclines on fetal and maternal cardiac function

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 12, 2012, Pages 1465-1468

  Gziri, Mina Mhallem ^a   Debiève, Frédéric ^b   De Catte, Luc ^a   Mertens, Luc ^c,d   Barrea, Catherine ^b   Van Calsteren, Kristel ^a   Han, Sileny N ^a   Heyns, Liesbeth ^a   Amant, Frédéric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

anthracyclines; cancer; cardiotoxicity; echocardiography; Pregnancy

Indexed keywords

ANTHRACYCLINE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; FEMALE; FETUS; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; IMAGE ANALYSIS; MULTIPLE CYCLE TREATMENT; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; ULTRASOUND SCANNER;

ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BELGIUM; CASE-CONTROL STUDIES; FEMALE; FETAL HEART; HUMANS; INFANT, NEWBORN; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 84870901064     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01524.x     Document Type: Article

References (12)

1. Pavlidis N,. Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer? Eur J Cancer. 2011; 47: S348-52.
2. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB,. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol. 2008; 26: 3777-84.
3. Amant F, Loibl S, Neven P, Van Calsteren K,. Breast cancer in pregnancy. Lancet. 2012; 379: 570-9.
4. Cardonick E, Usmani A, Ghaffar S,. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010; 33: 221-8.
5. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, et al,. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010; 28: 683-9.
6. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, et al,. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13: 256-64.
7. Meyer-Wittkopf M, Barth H, Emons G, Schmidt S,. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol. 2001; 18: 62-6.
8. Devore GR,. Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med. 2005; 10: 515-41.
9. Hernandez-Andrade E, Lopez-Tenorio J, Figueroa-Diesel H, Sanin-Blair J, Carreras E, Cabero L, et al,. A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function assessment. Ultrasound Obstet Gynecol. 2005; 26: 227-32.
10. Baumgartner AK, Oberhoffer R, Jacobs VR, Ostermayer E, Menzel H, Voigt M, et al,. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie. 2009; 32: 40-3.
11. Reynoso EE, Huerta F,. Acute leukemia and pregnancy-fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol. 1994; 33: 709-10.
12. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D'hooge J, et al,. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol. 2007; 99: 974-7.